Dr. Helena Yu, MD
- Publications
- 134
- Clinical trials
- 8
- Hospital affiliations
- 1
- Industry payments
- $6,730
- Medical group
- 1
- Practice address
- 3020 Childrens Way, San Diego, CA 92123
- Practice phone
- Call (858) 576-1700
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Yu's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Helena Yu is a pediatric hematology and oncology physician in San Diego, California
Dr. Yu practices at Rady Children's Hospital San Diego in San Diego, California, part of Rady Children's Health.
Dr. Yu's NPI, 1881127736, was assigned on April 7, 2017. Dr. Yu graduated from Keck School of Medicine of USC in 2017. Dr. Yu holds California license A157114.
- NPI
- 1881127736NPI Registry (opens in a new tab)
- NPI enumeration date
- April 7, 2017
- NPI status
- Active
- Practice phone
- (858) 576-1700
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Medical school graduation
- 2017
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Helena Yu practices at Rady Children's Hospital San Diego in San Diego, California
Dr. Yu's primary practice is Rady Children's Hospital San Diego, at 3020 Childrens Way, San Diego, CA 92123 in San Diego County. The practice phone is (858) 576-1700.
- Rady Children's Hospital San Diego3020 Childrens Way, San Diego, CA 92123 · San Diego CountyPhone(858) 576-1700
Source: Dmand AI Affiliation Data
Dr. Helena Yu is affiliated with 3 sites of care and 1 medical group
Dr. Yu's primary practice is Rady Children's Hospital San Diego in San Diego, California, part of Rady Children's Health. The medical group on file is Rady Children's Specialists of San Diego. Dmand AI also links Dr. Yu to 1 more group practice or clinic and 1 therapy and rehab clinic, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Helena Yu's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yu practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Rady Children's Hospital San Diego | Available with a free account |
| +2 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Rady Children's Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Helena Yu is one of 385 pediatric hematologys and oncology physicians in California
Pediatric hematology-oncology is Dr. Yu's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Yu is licensed in California.
Specialties and state licenses
- Pediatric hematology and oncology, CaliforniaPrimary
Pediatric hematologys and oncology physicians near Dr. Yu
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Helena Yu's patients have a median age of 11
Across all payers, Dmand AI patient panel data puts Dr. Yu's median patient age at 11, with 51% women.
Dr. Yu's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 11
Patient panel by sex, all payers
- Women51%
- Men48%
Source: Dmand AI Patient Panel Data
Dr. Helena Yu has 134 publications on record
Dmand AI links 134 papers to Dr. Yu, published from 2012 to 2025. 2021 was the busiest year, with 15. The most frequent topics are Lung Neoplasms, ErbB Receptors and Carcinoma, Non-Small-Cell Lung. Dr. Yu has published most often in Clin Cancer Res. Dr. Yu's most frequent co-authors are Mark G. Kris, MD, Charles M. Rudin, MD, PhD and Gregory J. Riely, MD.
Dr. Yu's papers by year, 2016 to 2025
Topics Dr. Yu writes about most
- Lung Neoplasms
- ErbB Receptors
- Carcinoma, Non-Small-Cell Lung
- Protein Kinase Inhibitors
- Drug Resistance, Neoplasm
- Aniline Compounds
- Acrylamides
- Adenocarcinoma
Dr. Yu's most frequent co-authors
- Mark G. Kris, MD47 shared papers
- Charles M. Rudin, MD, PhD33 shared papers
- Gregory J. Riely, MD27 shared papers
Recent publications by Dr. Yu
See who Dr. Yu researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Yu works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Helena Yu has worked on 8 clinical trials
Dmand AI links Dr. Yu to 8 clinical trials, 3 of them phase 1 studies. 4 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Lung Neoplasms. Memorial Sloan Kettering Cancer Center sponsors the most, 5.
Clinical trials with Dr. Yu by phase
- 3Phase 1: 3 trials
- 2Phase 1/2: 2 trials
- 1Phase 2: 1 trial
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Yu's trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
- Lung Neoplasms
- Neoplasm Metastasis
- Noonan Syndrome
Investigators on the most trials with Dr. Yu
- Todd Adam Gersten, MD1 shared trial
- Michael J. McCleod, DO1 shared trial
- Zofia Piotrowska, MD1 shared trial
Recent clinical trials with Dr. Yu
An Open-label, Multi-center, Phase I, Dose Finding Study of Oral TNO155 in Adult Patients With Advanced Solid Tumors (opens in a new tab)
A Phase 2 Single-Arm Study of Amivantamab (JNJ-61186372) and Lazertinib in Metastatic EGFR-mutant Lung Cancer With Progressive or New CNS Metastases on Previous Treatment (opens in a new tab)
Phase 1 Study of Combination Dacomitinib and Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers (opens in a new tab)
Phase 1 Study of Combination Osimertinib, Platinum, Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers With Concurrent RB1 and TP53 Alterations (opens in a new tab)
A Phase 1/2 Study of Combination Osimertinib and Bevacizumab as Treatment for Patients With EGFR-mutant Lung Cancers (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Helena Yu received $6,730 in industry payments from 2020 to 2025
CMS Open Payments shows 16 general payments to Dr. Yu from 7 drug and device companies from 2020 to 2025. Consulting fees make up the largest share, 75% of the total. Janssen Pharmaceuticals, Inc paid the most, $5,200.
General payments to Dr. Yu by program year, 2020 to 2025
General payments to Dr. Yu by kind, 2020 to 2025
- Consulting fees$5,07575%
- Food and beverage$86213%
- Travel and lodging$79312%
Companies that paid Dr. Yu the most, 2020 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Helena Yu graduated from Keck School of Medicine of USC
Dr. Yu graduated from Keck School of Medicine of USC in 2017.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Helena Yu's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Helena Yu
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Helena Yu's NPI number?
Dr. Helena Yu's NPI number is 1881127736. It was assigned on April 7, 2017, and it is active in the NPI Registry.
What kind of doctor is Dr. Helena Yu?
Dr. Helena Yu is a pediatric hematology and oncology physician in San Diego, California. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Helena Yu practice?
Dr. Yu practices at 3020 Childrens Way, San Diego, CA 92123. Dr. Yu's primary practice is Rady Children's Hospital San Diego in San Diego, California, part of Rady Children's Health. Dmand AI also links Dr. Yu to 1 group practice or clinic and 1 therapy and rehab clinic.
What is Dr. Helena Yu's office phone number?
The practice phone on file for Dr. Yu is (858) 576-1700.
What is Dr. Helena Yu's medical license number?
Dr. Yu holds California license A157114.
Which hospitals is Dr. Helena Yu affiliated with?
Dr. Yu practices at Rady Children's Hospital San Diego in San Diego, California.
What medical group is Dr. Helena Yu part of?
Dr. Yu is linked to Rady Children's Specialists of San Diego.
Where did Dr. Helena Yu go to medical school?
Dr. Yu graduated from Keck School of Medicine of USC in 2017.
Has Dr. Helena Yu received payments from drug or device companies?
CMS Open Payments shows $6,730 in general payments to Dr. Yu from 7 companies from 2020 to 2025. The largest total came from Janssen Pharmaceuticals, Inc.
How long has Dr. Helena Yu been practicing?
Dr. Yu graduated from medical school in 2017, 9 years ago.
Does Dr. Helena Yu do research?
Dmand AI links 134 publications to Dr. Yu, published from 2012 to 2025. Dr. Yu has worked on 8 clinical trials.
Who does Dr. Helena Yu publish with?
Dr. Yu's most frequent co-authors are Mark G. Kris, MD (47 shared papers), Charles M. Rudin, MD, PhD (33 shared papers) and Gregory J. Riely, MD (27 shared papers).
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card